Prosecution Insights
Last updated: November 04, 2026

Hui-Ju Tsai

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Hui-Ju Tsai is currently navigating the patent prosecution process within the Biotechnology & Pharmaceuticals technology area. The portfolio contains 1 pending office action, which represents the current focus of the legal efforts. This 1 pending office action suggests a targeted approach to securing intellectual property in the biotech field. Protecting innovations in Biotechnology & Pharmaceuticals requires a clear understanding of the specific examination standards applied to these biological technologies.

The examination of these assets is conducted by 1 distinct examiner and is situated within 1 distinct art unit. This arrangement indicates that the technical subject matter is concentrated within a specific administrative group at the patent office. For the applicant, this means that the prosecution path is centralized under a single point of review. The presence of 1 distinct art unit further implies that the portfolio assets share a common technical foundation within the 1 distinct examiner's area of expertise.

CHUNDURU, SURYAPRABHA is the busiest examiner for the portfolio, currently managing 1 busiest examiner pending office action. As this examiner is responsible for the only pending action, the outcome of the current prosecution is dependent on their specific evaluation. This relationship between pending actions and 1 distinct examiner simplifies the management of the portfolio. Practitioners should address the specific concerns of CHUNDURU, SURYAPRABHA to move the 1 busiest examiner pending office action toward a resolution.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§102 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
CHUNDURU, SURYAPRABHA 1 53.3% +17.4%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17869367 SYSTEM AND METHOD OF BIOCHEMICAL MOLECULE SYNTHESIS AND DETECTION IN A POINT OF COLLECTION SETTING CHUNDURU, SURYAPRABHA 11d overdue

Top Art Units

Art UnitApps
1681 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17869367 SYSTEM AND METHOD OF BIOCHEMICAL MOLECULE SYNTHESIS AND DETECTION IN A POINT OF COLLECTION SETTING CHUNDURU, SURYAPRABHA 1681 §102 Non-Final OA 11d overdue Pending Jul 20, 2022

Managing Hui-Ju Tsai's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Hui-Ju Tsai have?

Hui-Ju Tsai has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Hui-Ju Tsai applications?

Suryaprabha Chunduru has the most, with 1 of Hui-Ju Tsai's pending office actions.

What technology area are Hui-Ju Tsai's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month